| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,924 |
16,880 |
$360K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,240 |
2,164 |
$176K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,674 |
1,656 |
$146K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,753 |
1,737 |
$141K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12,877 |
5,924 |
$91K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,153 |
1,138 |
$86K |
| 90670 |
|
681 |
658 |
$86K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,522 |
3,629 |
$75K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,498 |
2,295 |
$61K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,126 |
8,432 |
$60K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
730 |
708 |
$50K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,368 |
2,133 |
$48K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,975 |
3,583 |
$45K |
| 90651 |
|
297 |
296 |
$27K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
187 |
182 |
$26K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
606 |
588 |
$19K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,034 |
987 |
$19K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
592 |
575 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,573 |
1,535 |
$17K |
| 90734 |
|
267 |
266 |
$16K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,381 |
4,840 |
$15K |
| 87081 |
|
2,193 |
2,060 |
$12K |
| 87634 |
|
198 |
183 |
$10K |
| 90716 |
|
137 |
134 |
$9K |
| 90620 |
|
102 |
100 |
$9K |
| 87428 |
|
341 |
334 |
$7K |
| 90680 |
|
310 |
300 |
$6K |
| 90461 |
|
749 |
728 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
267 |
253 |
$5K |
| 90707 |
|
136 |
132 |
$5K |
| 90686 |
|
768 |
758 |
$5K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
609 |
604 |
$5K |
| 90723 |
|
141 |
139 |
$4K |
| 87581 |
|
106 |
105 |
$3K |
| 0071A |
|
62 |
56 |
$2K |
| 90648 |
|
279 |
274 |
$2K |
| 90633 |
|
186 |
180 |
$2K |
| 0072A |
|
46 |
46 |
$2K |
| 87809 |
|
79 |
72 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
13 |
12 |
$1K |
| 99381 |
|
13 |
12 |
$929.61 |
| 90715 |
|
51 |
51 |
$915.78 |
| 86318 |
|
53 |
53 |
$904.50 |
| 97169 |
|
18 |
18 |
$850.00 |
| 82570 |
|
166 |
164 |
$687.24 |
| 86308 |
|
144 |
140 |
$597.69 |
| 96160 |
|
537 |
533 |
$495.26 |
| 81003 |
|
566 |
542 |
$448.08 |
| 92567 |
|
31 |
28 |
$328.41 |
| 90688 |
|
214 |
214 |
$151.22 |
| 87807 |
|
336 |
300 |
$66.00 |
| 87400 |
|
44 |
19 |
$23.74 |
| 90671 |
|
120 |
117 |
$0.09 |
| 91307 |
|
108 |
94 |
$0.00 |
| 90697 |
|
141 |
134 |
$0.00 |
| 90696 |
|
26 |
26 |
$0.00 |
| 97802 |
|
102 |
102 |
$0.00 |
| 90677 |
|
12 |
12 |
$0.00 |
| 90700 |
|
13 |
13 |
$0.00 |
| 90681 |
|
34 |
34 |
$0.00 |